← Back to Search

Transcranial Direct Current Stimulation

Transcranial direct current stimulation (high-definition) for Stroke

N/A
Recruiting
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (initial visit), before (within 30 min range) and immediately after (within 30 mins range) the intervention
Awards & highlights

Study Summary

This trial will test whether a targeted brain stimulation called HD-tDCS can help reduce muscle synergy impairment, which is a major limitation to the recovery of independent function after a stroke.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (initial visit), before (within 30 min range) and immediately after (within 30 mins range) the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (initial visit), before (within 30 min range) and immediately after (within 30 mins range) the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in a subset of Fugl-Meyer Upper Extremity assessment which is mainly related to the muscle synergies
Secondary outcome measures
Change in Transcranial magnetic stimulation (TMS)-evoke motor-evoked potentials (MEP)
Other outcome measures
Change in Brain symmetry index

Trial Design

3Treatment groups
Experimental Treatment
Group I: Sham stimulationExperimental Treatment1 Intervention
Sham stimulation to the brain
Group II: Cathodal stimulationExperimental Treatment1 Intervention
Cathodal one at the contralesional hemisphere
Group III: Anodal stimulationExperimental Treatment1 Intervention
Anodal stimulation targeting hemisphere

Find a Location

Who is running the clinical trial?

Oklahoma Shared Clinical and Translational ResourcesUNKNOWN
1 Previous Clinical Trials
32 Total Patients Enrolled
University of OklahomaLead Sponsor
455 Previous Clinical Trials
95,819 Total Patients Enrolled
3 Trials studying Stroke
84 Patients Enrolled for Stroke

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research have an age cutoff for participants?

"This clinical trial is only open to patients between 18 and 90 years old. Alternatively, there are 38 trials for individuals below the age of majority and 1006 studies available for those over 65."

Answered by AI

Do I meet the criteria to partake in this medical experiment?

"This experiment requires 12 individuals who have suffered a stroke, aged 18 to 90. Most importantly, they must possess paresis limited to one side of their body and moderate-severe motor impairment in their upper extremity (Fugl-Meyer score between 10 - 40)."

Answered by AI

How many participants are being allowed to partake in this clinical exploration?

"Yes, per the information on clinicaltrials.gov, this medical trial is presently enrolling participants. It was initially brought to attention in January 18th 2022 and has been modified as of October 31st 2022. The study requires 12 volunteers from a single site for completion."

Answered by AI

Are there still vacancies in this research endeavor?

"Affirmative. Clinicaltrials.gov provides evidence that this medical experiment is actively looking for volunteers, which was first posted on January 18th 2022 and last edited in October 31st 2022. This study requires 12 participants from one clinical site."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What site did they apply to?
University of Oklahoma Health Sciences Center
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Targeted High-definition Transcranial Direct Current Stimulation (HD-tDCS) for Reducing Post-stroke Movement Impairments
2022. "Targeted High-definition Transcranial Direct Current Stimulation (HD-tDCS) for Reducing Post-stroke Movement Impairments". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05174949.
All > Tdcs
~4 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top